About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Multidisciplinary Nursing Research Group develops its research with the commitment to solve and prevent people's health problems. It is a team made up of nurses, midwives, physiotherapists, occupational therapists, nutritionists and social workers, whose objective is to generate knowledge in the specific area of nursing activity and other health professionals. With special interest in populations of extreme age, critical, chronic and complex chronic patients. The main lines of research are focused on the ethical and social aspects of care, innovative technologies in health, innovative technologies in therapeutic applications and health promotion for the autonomy of patients and families.
In its first 8 years of activity, the group has published 70 international papers, achieved 8 competitive findings, finalized PhD thesis and validated and implemented different innovative care models.
IP: -
IP: Begoña Benito Villabriga Collaborators: Carmen Escudero Iriarte, Laia Ventura i Expósito, Susana Otero Romero, Ignacio Ferreira González, José Antonio Barrabés Riu, Carlos Nos Llopis, Pablo Velasco Puyó, Jose Fernando Rodríguez Palomares, Belen Perez Dueñas, Jaume Sastre Garriga, Joan López Hellin, Antonia Sambola Ayala, Jordi Rio Izquierdo, Nuria Rivas Gandara, Jordi Perez Rodon, Aroa Soriano Fernández, Manuel Comabella Lopez, Antonio Rodríguez Sinovas, Gisela Teixido i Tura, Antonia Pijuan Domenech, Roser Ferrer Costa, Carmen Tur Gomez, Maria Cristina Díaz de Heredia Rubio, Laia Yañez Bisbe, Maria Jose Pérez García, Miguel Segura Ginard, Cristina Auger Acosta, Neus Bellera Gotarda, Herena Eixarch Ahufinger, M Mar Mañu Pereira, Deborah Pareto Onghena, Lorena Valero Arrese, Aitor Uribarri Gonzalez, Jordi Bañeras Rius, Alex Rovira Cañellas, Mar Tintore Subirana, Bruno Garcia del Blanco, Ana Vivancos Prellezo, Maria Teresa Salcedo Allende, Marisol Ruiz Meana, Ana Belén Méndez Fernández, Anna Llort Sales, Carmen Espejo Ruiz, Raquel Hladun Alvaro, Sandra Mancilla Zamora, Ana Zabalza de Torres, Marc Miquel Moltó Abad, Javier Inserte Igual, Luciana Midaglia Fernandez, Gabriela Guillén Burrieza, David Gómez Andrés, Alvaro Cobo Calvo, Alvaro Calabuig Goena, Joaquin Castillo Justribo, Lucas Moreno Martín-Retortillo, Andres Miguez Gonzalez, Josep Roma Castanyer, Laura Dos Subirá, Jaume Capdevila Castillon, Nicolás Miguel Fissolo , Maria Nazarena Pizzi, Paolo Giovanni Nuciforo, Tian Tian, Andrea Guala , Juan Pablo Betancur Rengifo Funding agency: Instituto de Salud Carlos III Funding: 2494527.53 Reference: FORT23/00034 Duration: 01/01/2024 - 31/12/2027
IP: Beatriz Hernandez Mendez Collaborators: Laia Perez Lasarte Funding agency: Fundació Institut de Recerca HUVH Funding: 42429.8 Reference: VHIR-INT-2023-004 Duration: 08/11/2023 - 07/11/2025
IP: Monica Rodriguez Carballeira Collaborators: Montserrat Juárez Vives, AIDA RIBERA SOLÉ, Xarxa R+D+I en Tecnologies de la Salut (Xartec Salut)., Daniel Sevilla Sánchez, Marcos Pérez Carrasco, Jordi Bañeras Rius, Marta Molins Sauri, Laura Mónica Perez Bazan, Neus Gual Tarrada, Meritxell Jiménez Llahí, Ana Maria De Andres Lázaro, Ignasi Maspons Molins, Xarxa R+D+I en Tecnologies de la Salut (Xartec Salut)., Lorena Villa García, Marco Inzitari, Sofia Contreras Medina Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 0.01 Reference: 2022 XARDI 00021 Duration: 01/01/2023 - 31/12/2025
IP: Zahira Perez Martinez Collaborators: - Funding agency: European Chron's and Colitis Organisation – ECCO Funding: 20000 Reference: RGA_Z.PEREZ_N-ECCO_2022 Duration: 01/01/2023 - 31/12/2024
The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.
The recognition highlights the Cuidador Acompañante project, a nursing-led initiative that promotes the active and safe participation of families in the Intensive Care Unit (ICU).
Critical thinking enables these professionals to analyse each clinical situation more reflectively and rigorously in order to improve patient care.
